Literature DB >> 16458326

Atractyloside and 5-hydroxydecanoate block the protective effect of puerarin in isolated rat heart.

Qin Gao1, Hong-Yang Pan, Shuang Qiu, Yuan Lu, Iain C Bruce, Jian-Hong Luo, Qiang Xia.   

Abstract

The aim of the present study was to determine whether the clinically effective cardioprotection conferred by puerarin (Pue) against ischemia and reperfusion is mediated by mitochondrial transmembrane pores and/or channels. Hearts isolated from male Sprague-Dawley rats were perfused on a Langendorff apparatus and subjected to 30 min of global ischemia followed by 120 min of reperfusion. The production of formazan, which provides an index of myocardial viability, was measured by absorbance at 550 nm, and the level of lactate dehydrogenase (LDH) in the coronary effluent was determined. In this model, Pue (0.0024-2.4 mmol/l) had a dose-dependent, negatively inotropic effect. Pretreatment with Pue at 0.24 mmol/l for 5 min before ischemia increased myocardial formazan content, reduced LDH release, improved recovery of left ventricular end-diastolic pressure and rate-pressure product (left ventricular developed pressure multiplied by heart rate) during reperfusion. Administration of atractyloside (20 micromol/l), an opener of the mitochondrial permeability transition pore, for the first 20 min of reperfusion, and 5-hydroxydecanoate (100 micromol/l), the mitochondrial-specific ATP-sensitive potassium channel blocker, for 20 min before ischemia, attenuated the protective effects of Pue. In mitochondria isolated from hearts pretreated with 0.24 mmol/l Pue for 5 min, a significant inhibition of Ca(2+)-induced swelling was observed, and this inhibition was attenuated by 5-hydroxydecanoate. In isolated ventricular myocytes, pretreatment with Pue prevented ischemia-induced cell death and depolarization of the mitochondrial membrane, and atractyloside and 5-hydroxydecanoate attenuated the effects of Pue. These findings indicate that puerarin protects the myocardium against ischemia and reperfusion injury via inhibiting mitochondrial permeability transition pore opening and activating the mitochondrial ATP-sensitive potassium channel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16458326     DOI: 10.1016/j.lfs.2005.12.040

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Reducing the oxidative stress mediates the cardioprotection of bicyclol against ischemia-reperfusion injury in rats.

Authors:  Jie Cui; Zhi Li; Ling-bo Qian; Qin Gao; Jue Wang; Meng Xue; Xiao-e Lou; Iain C Bruce; Qiang Xia; Hui-ping Wang
Journal:  J Zhejiang Univ Sci B       Date:  2013-06       Impact factor: 3.066

2.  The Effects of Puerarin on Rat Ventricular Myocytes and the Potential Mechanism.

Authors:  Hao Xu; Manxi Zhao; Shenghui Liang; Quanshu Huang; Yunchuan Xiao; Liang Ye; Qinyi Wang; Longmei He; Lanxiang Ma; Hua Zhang; Li Zhang; Hui Jiang; Xiao Ke; Yuchun Gu
Journal:  Sci Rep       Date:  2016-10-20       Impact factor: 4.379

Review 3.  Puerarin: A protective drug against ischemia-reperfusion injury.

Authors:  Minglang Gao; Ziyao Zhang; Kai Lai; Yu Deng; Chuanbing Zhao; Zilong Lu; Qing Geng
Journal:  Front Pharmacol       Date:  2022-08-24       Impact factor: 5.988

4.  Screening potential mitochondria-targeting compounds from traditional Chinese medicines using a mitochondria-based centrifugal ultrafiltration/liquid chromatography/mass spectrometry method.

Authors:  Xing-Xin Yang; Yu-Zhen Zhou; Feng Xu; Jie Yu; Ming-Ying Shang; Xuan Wang; Shao-Qing Cai
Journal:  J Pharm Anal       Date:  2018-06-15

Review 5.  Effects of Puerarin on the Prevention and Treatment of Cardiovascular Diseases.

Authors:  Yan-Xi Zhou; Hong Zhang; Cheng Peng
Journal:  Front Pharmacol       Date:  2021-12-07       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.